Medicare Enrolled
Dr. Henry Shapiro, MD
Optician · Jupiter, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shapiro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shapiro? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shapiro
Dr. Henry Shapiro is an optician in Jupiter, FL, with 19 years in practice. Based on federal Medicare data, Dr. Shapiro performed 40,389 Medicare services across 2,168 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shapiro received a total of $10,849 from 75 pharmaceutical and/or device companies across 657 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shapiro is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in FL$ $10,849 industry payments
Medicare Practice Summary
Medicare Utilization ↗40,389
Medicare services
Top 2% in FL for optician
2,168
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,126 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 18,870 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia | 9,920 | $6 | $33 |
| Contrast dye for imaging (iodine-based) | 3,500 | $0 | $1 |
| Dexamethasone injection (steroid) | 1,464 | $0 | $1 |
| Blood draw (venipuncture) | 1,290 | $8 | $14 |
| Complete blood count (CBC) with differential | 1,090 | $8 | $34 |
| Comprehensive metabolic blood panel | 716 | $10 | $46 |
| Office visit, established patient (30-39 min) | 701 | $99 | $319 |
| Lactate dehydrogenase (enzyme) level | 520 | $6 | $26 |
| Drug injection, under skin or into muscle | 489 | $12 | $72 |
| Bilirubin level, direct | 376 | $5 | $22 |
| Administration of chemotherapy into vein, 1 hour or less | 173 | $106 | $461 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 154 | $24 | $102 |
| Hospital follow-up visit, moderate complexity | 154 | $66 | $213 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 133 | $58 | $228 |
| Carcinoembryonic antigen (cea) protein level | 114 | $18 | $82 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 105 | $51 | $223 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 69 | $1,188 | $3,581 |
| New patient office visit, complex (60-74 min) | 67 | $174 | $626 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 63 | $410 | $982 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 53 | $4 | $15 |
| Magnesium level test | 50 | $7 | $28 |
| Thyroid stimulating hormone (TSH) test | 48 | $16 | $73 |
| Free thyroxine (T4) test | 46 | $9 | $39 |
| Initial hospital admission, high complexity | 45 | $145 | $621 |
| Office visit, established patient, complex (40-54 min) | 40 | $149 | $390 |
| CT scan of chest, without contrast | 36 | $51 | $649 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 30 | $20 | $89 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | 27 | $20 | $89 |
| New patient office visit (45-59 min) | 16 | $139 | $328 |
| Ct scan of chest with contrast | 15 | $60 | $807 |
| CT scan of abdomen and pelvis with contrast | 15 | $152 | $812 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
47.4% high complexity
39.2% medium
13.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,849
Total received (2018-2024)
Avg $1,550/year across 7 years
Top 13% in FL for optician
75
Companies
657
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,277 (94.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$572 (5.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,163
2023$2,309
2022$1,929
2021$1,729
2020$590
2019$942
2018$1,186
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,190
Celgene Corporation
$669
Janssen Biotech, Inc.
$613
Genentech USA, Inc.
$594
Astellas Pharma US Inc
$499
AstraZeneca Pharmaceuticals LP
$495
GENZYME CORPORATION
$463
Incyte Corporation
$445
Lilly USA, LLC
$429
E.R. Squibb & Sons, L.L.C.
$409
Novartis Pharmaceuticals Corporation
$353
Daiichi Sankyo Inc.
$341
Amgen Inc.
$274
Merck Sharp & Dohme LLC
$262
Seagen Inc.
$172
GlaxoSmithKline, LLC.
$170
Eisai Inc.
$163
Takeda Pharmaceuticals U.S.A., Inc.
$152
Pharmacyclics LLC, An AbbVie Company
$151
ARRAY BIOPHARMA INC
$139
ABBVIE INC.
$132
Rigel Pharmaceuticals, Inc.
$132
Bayer HealthCare Pharmaceuticals Inc.
$125
Adaptive Biotechnologies Corporation
$120
Seattle Genetics, Inc.
$116
Ipsen Biopharmaceuticals, Inc
$115
BeiGene USA, Inc.
$115
Sirtex Medical Inc
$111
Medtronic USA, Inc.
$108
AbbVie Inc.
$105
Merck Sharp & Dohme Corporation
$105
Foundation Medicine, Inc.
$93
Kite Pharma, Inc.
$72
Puma Biotechnology, Inc.
$71
Exelixis Inc.
$62
Stemline Therapeutics Inc.
$62
Bayer Healthcare Pharmaceuticals Inc.
$60
PharmaEssentia USA Corporation
$60
SOBI, INC
$58
Regeneron Healthcare Solutions, Inc.
$56
Amneal Pharmaceuticals LLC
$52
SERVIER PHARMACEUTICALS LLC
$49
MEDIVATION FIELD SOLUTIONS LLC
$48
EMD Serono, Inc.
$47
PUMA BIOTECHNOLOGY, INC.
$46
AVEO Pharmaceuticals, Inc.
$41
Karyopharm Therapeutics Inc.
$41
Kyowa Kirin, Inc.
$39
CTI BioPharma Corp.
$39
Gilead Sciences, Inc.
$35
Deciphera Pharmaceuticals Inc.
$34
Otsuka America Pharmaceutical, Inc.
$34
Mirati Therapeutics, Inc.
$33
Pharmacyclics LLC, an AbbVie Company
$33
JAZZ PHARMACEUTICALS INC.
$31
MorphoSys, US Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Biocon Biologics Inc
$24
Legend Biotech USA Inc.
$24
TG Therapeutics, Inc.
$23
AbbVie, Inc.
$22
Fennec Pharmaceuticals, Inc.
$22
ImmunoGen, Inc.
$20
TAIHO ONCOLOGY, INC.
$19
Acceleron Pharma, Inc.
$19
Alexion Pharmaceuticals, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Array BioPharma Inc.
$17
Myovant Sciences Inc.
$16
TG THERAPEUTICS, INC.
$16
Blueprint Medicines Corporation
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Aurobindo Pharma USA, Inc.
$14
Sumitomo Pharma America, Inc.
$14
Advanced Accelerator Applications
$11
Top 3 companies account for 22.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · AUGTYRO · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Braftovi · CABLIVI · CABOMETYX · CARVYKTI · CYRAMZA · DARZALEX · DOPTELET · ELAHERE · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Enhertu · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · Fulphila · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · Padcev · Pedmark · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · UKONIQ · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Vectibix · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $27 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
200
Per 100K population
13.3
County median income
$81,115
Nearest hospital
JUPITER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shapiro is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 13%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shapiro experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Shapiro performed 18,870 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shapiro receive payments from pharmaceutical companies?
Yes. Dr. Shapiro received a total of $10,849 from 75 companies across 657 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shapiro's costs compare to other opticians in Jupiter?
Dr. Shapiro's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shapiro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Jupiter
Browse opticians in Jupiter ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology